Andrew Gellman

As President of Ingenus Pharmaceuticals, Mr. Gellman is responsible for providing leadership and tactical direction for the company. Prior to creating Ingenus, Mr. Gellman was the chief operating officer for ICORE Healthcare, a specialty drug management company focused on managing specialty drug spend for Payors. Previously, Mr. Gellman served as the President/GM of Integrated Commercialization Solutions (ICS), a third party logistics provider to the pharmaceutical industry.

Mr. Gellman holds a bachelor’s degree in business administration from the University of Michigan.

Location

Dallas, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Ingenus Pharmaceuticals

1 followers

Ingenus Pharmaceuticals is an emerging privately held U.S. based generic pharmaceutical company with manufacturing and research and development facilities in the U.S.,Switzerland, and India. Since 2010, Ingenus has been developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients and suppliers. With over 65 filings covering a wide range of therapeutic classes ,including transdermal, parenteral, semi-solids, injectable, and extended release products Ingenus is well positioned to becoming a leader in the generic pharmaceutical industry.


Employees

201-500

Links